insights_auto
Why is TNXP down 4,32%?
Dive Deeperchevron_right
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
USD 2,88
arrow_downward
-4,32%(-0,13) 1D
USD 2,93
arrow_upward
+1,74% (+0,050)bedtimeAfter hours
Closed: 16 Nov., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
USD 3,02
High
USD 3,08
Low
USD 2,81
Mkt. cap
55,96 m
Avg. vol.
1,16 m
Volume
0,00
52-wk high
USD 20,56
52-wk low
USD 2,81
EPS
-USD 12,92
Beta
1,90
Shares outstanding
19,43 m
No. of employees
142
Open
USD 3,02
High
USD 3,08
Low
USD 2,81
Mkt. cap
55,96 m
Avg. vol.
1,16 m
Volume
0,00
52-wk high
USD 20,56
52-wk low
USD 2,81
EPS
-USD 12,92
Beta
1,90
Shares outstanding
19,43 m
No. of employees
142
News stories
From web sources and news partners
Zacks Small Cap Research
·
16 uur gelede
TNXP: Tonmya® Launch Continues to Build Momentum; 37% QoQ Growth in Revenue
Yahoo Finance
·
4 dae gelede
TNXP 8-K & SEC Filings
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersBerkeley Heights, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitetonixpharma.com